https://ash.confex.com/ash/2023/webprogram/Paper173582.html [3]https://www.drugtargetreview.com/article/112476/car-nk-cells-promising-for-cancer-therapy/ [4]https://www.dana-farber.org/newsroom/features/making-natural-killer-cells-smarter-to-improve-cell-therapy ...
[3]https://www.drugtargetreview.com/article/112476/car-nk-cells-promising-for-cancer-therapy/ [4]https://www.dana-farber.org/newsroom/features/making-natural-killer-cells-smarter-to-improve-cell-therapy 本文为全球肿瘤...
REVIEW articleFront. Immunol., 15 February 2018 |https://doi.org/10.3389/fimmu.2018.00283 Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
所以只以“CARNK”为关键字去检索是没用的,根本搜不到,要以haNK、taNK为关键字进行检索才能检索到NantKwest公司的临床试验: 然而不幸的是,目前大多数综述性论文都没有意识到这一点(如下图所示,反正我看过的每一篇关于CAR-NK的Review都漏掉了不少临床试验),这在宣传上肯定是要出偏差的: 做研究要慎重啊! 参考...
Efficacy and Safety of Natural Killer Cell Therapy in Solid Tumors: A Systematic Review and Meta-Analysis CAR NK Cell Therapy: A Promising New Approach in Cancer Treatment 大家都在问的问题: 问题1: CAR-T细胞疗法的主要挑战是什么? CAR-T细胞疗法面临的主要挑战包括制造过程复杂、治疗费用高昂以及副作用...
NK细胞独特的生物学特性和不断改进的CAR结构使CAR-NK细胞疗法成为新一代抗肿瘤利器。CAR-NK研究热门靶点包括HER2、ERBB2、BCMA、CD19等,义翘神州热门靶点蛋白齐全,助力相关科学研究。
[2] Chan LY, Dass SA, Tye GJ, Imran SAM, Wan Kamarul Zaman WS, Nordin F. CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review. Biomedicines. 2022;10(4):804. Published 2022 Mar 30. doi:10.3390/biomedicines10040804 [3] Wang Y, ...
嵌合抗原受体工程T细胞(CAR-T)的免疫疗法彻底改变了恶性肿瘤的治疗,而作为人体免疫“拆迁队”的自然杀伤(NK)细胞,凭借着其毒副作用小、可同种异体应用的优势逐渐成为免疫治疗的一颗新星。 今天,小编跟大家分享的就是一篇Annual Review of Cancer Biology(IF=7.7)杂志发表的CAR NK细胞综述,文章综合讨论了CAR NK细胞...
1. CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI 2. Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study | Cancer Gene Therapy (nature.com) 发布于 2024-04-17 10:31・IP 属地北京 癌症治疗 治疗 肿瘤 ...
因此,可以通过调节CAR-T/NK细胞的代谢来提高治疗效果。 随着未来几年提供更多的临床数据,CAR-NK细胞疗法可能会导致肿瘤免疫疗法的革命性进展。 Mini-review CAR-NK for tumor immunotherapy: Clinical transformation and future prospects https://doi.org/10.1016/j.canlet.2019.11.033...